Trends

Viral proteases recognize substrates through a conserved shape, defining the substrate envelope.

A variant that does not bind inhibitors efficiently but still processes substrates is resistant.

Resistance mutations occur where inhibitors protrude outside of the substrate envelope.

High-potency inhibitors that fit within the substrate envelope can avoid resistance.

Resistance-avoiding strategies need to be included in structure-based drug design.